Skip to main content

Advertisement

SpringerLink
Log in

Colorectal Liver Metastasis: Current Concepts

  • Original Article
  • Published:
Indian Journal of Surgery Aims and scope Submit manuscript

Abstract

Management of colorectal liver metastasis (CRLM) has undergone significant changes in the recent past. Better understanding of the biologic behavior of the disease along with advancements in technology and systemic therapy have led to more favorable outcome after multimodal treatment in CRLM patients. Important changes in approach include emphasis on R0 resection with an adequate functioning remnant liver, liver volume remodeling techniques, more efficacious systemic therapy, non-surgical ablative therapies, and a multi-disciplinary approach. This review article addresses different issues related to the management of CRLM.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A et al (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87–108

    Article  PubMed  Google Scholar 

  2. World Health Organization (2002) Cancer incidence in five continents. The World Health Organization and the International Agency for Research on Cancer, Lyon

    Google Scholar 

  3. Mohandas KM (2011) Colorectal cancer in India: controversies, enigmas and primary prevention. Indian J Gastroenterol 30(1):3–6

    Article  CAS  PubMed  Google Scholar 

  4. Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F et al (2017 Apr) Global patterns and trends in colorectal cancer incidence and mortality. Gut 66(4):683–691

    Article  PubMed  Google Scholar 

  5. Frankel TL, D'Angelica MI (2014) Hepatic resection for colorectal metastases. J Surg Oncol 109:2–7

    Article  PubMed  Google Scholar 

  6. Altendorf-Hofmann A, Scheele J (2003) A critical review of the major indicators of prognosis after resection of hepatic metastases from colorectal carcinoma. Surg Oncol Clin N Am 12:165–192

    Article  PubMed  Google Scholar 

  7. Weiss L, Grundmann E, Torhost J et al (1986) Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies. J Pathol 150:195–203

    Article  CAS  PubMed  Google Scholar 

  8. Van Nordlinger B, Custem E, Rougier P et al (2007) Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European colorectal metastases treatment group. Eur J Cancer 43:2037–2045

    Article  CAS  PubMed  Google Scholar 

  9. Joshua Smith J, D’Angelica MI (2015) Surgical management of hepatic metastases of colorectal cancer. Hematol Oncol Clin N Am 29:61–84

    Article  Google Scholar 

  10. Woodington GF, Waugh JM (1963) Results of resection of metastatic tumors of the liver. Am J Surg 105:24–29

    Article  CAS  PubMed  Google Scholar 

  11. Wilson SM, Adson MA (1976) Surgical treatment of hepatic metastases from colorectal cancers. Arch Surg 111:330–334

    Article  CAS  PubMed  Google Scholar 

  12. Pestana C, Reitemeier RJ, Moertel CG et al (1964) The natural history of carcinoma of the colon and rectum. Am J Surg 108:826–829

    Article  CAS  PubMed  Google Scholar 

  13. Cady B, Monson DO, Swinton NW (1970) Survival of patients after colonic resection for carcinoma with simultaneous liver metastases. Surg Gynecol Obstet 131:697–700

    CAS  PubMed  Google Scholar 

  14. Lahr CJ, Soong SJ, Cloud G, Smith JW, Urist MM, Balch CM et al (1983) A multifactorial analysis of prognostic factors in patients with liver metastases from colorectal carcinoma. J Clin Oncol 1:720–726

    Article  CAS  PubMed  Google Scholar 

  15. Nordlinger B, Guiguet M, Vaillant JC, Balladur P, Boudjema K, Bachellier P, Jaeck D et al (1996) Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer 77(7):1254–1262

    Article  CAS  PubMed  Google Scholar 

  16. Fong Y, Fortner J, Sun RL et al (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230(3):309–318 [discussion: 318–21]

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. House MG, Ito H, Gonen M et al (2010) Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution. J Am Coll Surg 210(5):744–52–7752–5

    Article  Google Scholar 

  18. Ekberg H, Tranberg KG, Andersson R, Lundstedt C, Hägerstrand I, Ranstam J, Bengmark S et al (1986) Determinants of survival in liver resection for colorectal secondaries. Br J Surg 73:727–731

    Article  CAS  PubMed  Google Scholar 

  19. Nordlinger B, Guiguet M, Vaillant JC, Balladur P, Boudjema K, Bachellier P, Jaeck D et al (1996) Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Cancer 77:1254–1262

    Article  CAS  PubMed  Google Scholar 

  20. Iwatsuki S, Dvorchik I, Madariaga JR, Marsh JW, Dodson F, Bonham AC, Geller DA, Gayowski TJ, Fung JJ, Starzl TE et al (1999) Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. J Am Coll Surg 189:291–299

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Ueno H, Mochizuki H, Hatsuse K, Hase K, Yamamoto T et al (2000) Indicators for treatment strategies of colorectal liver metastases. Ann Surg 231:59–66

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Lise M, Bacchetti S, Da Pian P et al (2001) Patterns of recurrence after resection of colorectal liver metastases: prediction by models of outcome analysis. World J Surg 25:638–644

    Article  CAS  PubMed  Google Scholar 

  23. Nagashima I, Takada T, Matsuda K et al (2004) A new scoring system to classify patients with colorectal liver metastases: proposal of criteria to select candidates for hepatic resection. J Hepato-Biliary-Pancreat Surg 11:79–83

    Article  Google Scholar 

  24. Schindl M, Wigmore SJ, Currie EJ, Laengle F, Garden OJ et al (2005) Prognostic scoring in colorectal cancer liver metastases: development and validation. Arch Surg 140:183–189

    Article  PubMed  Google Scholar 

  25. Zakaria S, Donohue JH, Que FG, Farnell MB, Schleck CD, Ilstrup DM, Nagorney DM et al (2007) Hepatic resection for colorectal metastases: value for risk scoring systems? Ann Surg 246:183–191

    Article  PubMed  PubMed Central  Google Scholar 

  26. Malik HZ, Prasad KR, Halazun KJ et al (2007) Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases. Ann Surg 246:806–814

    Article  PubMed  Google Scholar 

  27. Rees M, Tekkis PP, Welsh FK et al (2008) Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg 247:125–135

    Article  PubMed  Google Scholar 

  28. Konopke R, Kersting S, Distler M, Dietrich J, Gastmeier J, Heller A, Kulisch E, Saeger HD et al (2009) Prognostic factors and evaluation of a clinical score for predicting survival after resection of colorectal liver metastases. Liver Int 29:89–102

    Article  PubMed  Google Scholar 

  29. Greroire E, Hoti E, Gorden DL et al (2010) Utility or futility of prognostic scoring systems for colorectal liver metastases in an era of advanced multimodal therapy. Eur J Surg Oncol 36(6):568–574

    Article  Google Scholar 

  30. Gomez D, Cameron IC (2010) Prognostic scores for colorectal liver metastasis: clinically important or an academic exercise? HPB 12:227–238

    Article  PubMed  PubMed Central  Google Scholar 

  31. Sasaki K, Morioka D, Conci S et al (2016) The Tumor Burden Score: a new “metro-ticket” prognostic tool for colorectal liver metastases based on tumor size and number of tumors. Ann Surg. https://doi.org/10.1097/SLA.0000000000002064

  32. Reddy SK, Barbas AS, Clary BM (2009) Synchronous colorectal liver metastases: is it time to reconsider traditional paradigms of management? Ann Surg Oncol 16(9):2395–2410

    Article  PubMed  Google Scholar 

  33. Adam R, de Gramont A, Figueras J, for the EGOSLIM (Expert Group on OncoSurgery management of LIver Metastases) group et al (2015) Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus. Cancer Treat Rev 41:729–741

    Article  PubMed  Google Scholar 

  34. Wiering B, Ruers TJ, Krabbe PF et al (2007) Comparison of multiphase CT, FDG-PET and intra-operative ultrasound in patients with colorectal liver metastases selected for surgery. Ann Surg Oncol 14(2):818–826

    Article  CAS  PubMed  Google Scholar 

  35. Benoist S, Brouquet A, Penna C, Julié C, el Hajjam M, Chagnon S, Mitry E, Rougier P, Nordlinger B et al (2006) Complete response of colorectal liver metastases after chemotherapy: does it mean cure? J Clin Oncol 24(24):3939–3945

    Article  PubMed  Google Scholar 

  36. Adams RB, Aloia TA, Loyer E et al (2013) Selection for hepatic resection of colorectal liver metastases: expert consensus statement. HPB 15:91–103

    Article  PubMed  PubMed Central  Google Scholar 

  37. Rojas Llimpe FL, Di Fabio F, Ercolani G et al (2014) Imaging in resectable colorectal liver metastasis patients with or without preoperative chemotherapy: results of the PROMETEO-01 study. Br J Cancer 111:666–673

    Article  CAS  Google Scholar 

  38. Pawlik TM, Choti MA (2007) Surgical therapy for colorectal metastases to the liver. J Gastrointest Surg 11:1057–1077

    Article  PubMed  Google Scholar 

  39. Fretland ÅA, Dagenborg VJ, GMW B, on behalf of the Oslo-CoMet study group et al (2017) Laparoscopic versus open resection for colorectal liver metastases: the OSLO-COMET randomized controlled trial. Ann Surg. https://doi.org/10.1097/SLA.0000000000002353

  40. Kopetz S, Chang GJ, Overman MJ, Eng C, Sargent DJ, Larson DW, Grothey A, Vauthey JN, Nagorney DM, McWilliams R et al (2009) Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol 27:3677–3683

    Article  PubMed  PubMed Central  Google Scholar 

  41. Abulkhir A, Limongelli P, Healey AJ, Damrah O, Tait P, Jackson J, Habib N, Jiao LR et al (2008) Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann Surg 247(1):49–57

    Article  PubMed  Google Scholar 

  42. Leal JN, D’Angelica MI (2016) Modern locoregional treatment of colorectal cancer liver metastases. In: Morgan KA (ed) Current Controversies in Cancer Care for the Surgeon. Springer International Publishing Switzerland, Cham, pp 67–108. https://doi.org/10.1007/978-3-319-16205-8_5

    Chapter  Google Scholar 

  43. Hasselgren K, Sandström P, Bergthor B (2015) Role of associating liver partition and portal vein ligation for staged hepatectomy in colorectal liver metastases: a review. World J Gastroenterol 21(15):4491–4498

    Article  PubMed  PubMed Central  Google Scholar 

  44. Schadde E, Schnitzbauer AA, Tschuor C, Raptis DA, Bechstein WO, Clavien PA et al (2015) Systematic review and meta-analysis of feasibility, safety, and efficacy of a novel procedure: associating liver partition and portal vein ligation for staged hepatectomy. Ann Surg Oncol 22:3109–3120

    Article  PubMed  Google Scholar 

  45. Adam R, Laurent A, Azoulay D, Castaing D, Bismuth H et al (2000) Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors. Ann Surg 232:777–785

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Passot G, Chun YS, Kopetz SE, Zorzi D, Brudvik KW, Kim BJ, Conrad C, Aloia TA, Vauthey JN et al (2016) Predictors of safety and efficacy of 2-stage hepatectomy for bilateral colorectal liver metastases. J Am Coll Surg 223(1):99–108

    Article  PubMed  PubMed Central  Google Scholar 

  47. Adam R, Wicherts DA, de Haas RJ et al (2009) Patients with initially unresectable colorectal liver metastases: is there a possibility of cure? J Clin Oncol 27(11):1829–1835

    Article  PubMed  Google Scholar 

  48. Kemeny N (2010) The management of resectable and unresectable liver metastases from colorectal cancer. Curr Opin Oncol 22(4):364–373

    Article  PubMed  Google Scholar 

  49. Masi G, Loupakis F, Pollina L, Vasile E, Cupini S, Ricci S, Brunetti IM, Ferraldeschi R, Naso G, Filipponi F, Pietrabissa A, Goletti O, Baldi G, Fornaro L, Andreuccetti M, Falcone A et al (2009) Long-term outcome of initially unresectable metastatic colorectal cancer patients treated with 5-fluorouracil/leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) followed by radical surgery of metastases. Ann Surg 249(3):420–425

    Article  PubMed  Google Scholar 

  50. Adam R, De Gramont A, Figueras J, Guthrie A et al (2012) The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus. Oncologist 17(10):1225–1239

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Passot G, Soubrane O, Giuliante F et al (2017) Recent advances in chemotherapy and surgery for colorectal liver metastases. Liver Cancer 6:72–79

    Article  Google Scholar 

  52. Bischof DA, Clary BM, Maithel SK, Pawlik TM (2013) Surgical management of disappearing colorectal liver metastases. Br J Surg 100(11):1414–1420

    Article  CAS  PubMed  Google Scholar 

  53. Leal JN, D’Angelica MI (2016) Modern locoregional treatment of colorectal cancer liver metastases. In: Morgan KA (ed) Current Controversies in Cancer Care for the Surgeon. Springer International Publishing Switzerland, Cham, pp 67–109. https://doi.org/10.1007/978-3-319-16205-8_5

    Chapter  Google Scholar 

  54. van Vledder MG, de Jong MC, Pawlik TM, Schulick RD, Diaz LA, Choti MA et al (2010) Disappearing colorectal liver metastases after chemotherapy: should we be concerned? J Gastrointest Surg 14(11):1691–1700

    Article  PubMed  Google Scholar 

  55. Adams RB, Aloia TA, Loyer E, Pawlik TM, Taouli B, Vauthey JN, Americas Hepato-Pancreato-Biliary Association, Society of Surgical Oncology, Society for Surgery of the Alimentary Tract et al (2013) Selection for hepatic resection of colorectal liver metastases: expert consensus statement. HPB 15:91–103

    Article  PubMed  PubMed Central  Google Scholar 

  56. Adson MA, van Heerden JA, Adson MH, Wagner JS, Ilstrup DM et al (1984) Resection of hepatic metastases from colorectal cancer. Arch Surg 119(6):647–651

    Article  CAS  PubMed  Google Scholar 

  57. Blumgart LH, Fong Y (1995) Surgical options in the treatment of hepatic metastasis from colorectal cancer. Curr Probl Surg 32(5):333–421

    Article  CAS  PubMed  Google Scholar 

  58. Ferrarotto R, Pathak P, Maru D, Agarwal A, Overman M, Hoff PM, Kopetz S et al (2011) Durable complete responses in metastatic colorectal cancer treated with chemotherapy alone. Clin Colorectal Cancer 10:178–182

    Article  CAS  PubMed  Google Scholar 

  59. Chua TC, Saxena A, Liauw W, Kokandi A, Morris DL et al (2010) Systematic review of randomized and nonrandomized trials of the clinical response and outcomes of neoadjuvant systemic chemotherapy for resectable colorectal liver metastases. Ann Surg Oncol 17(2):492–501

    Article  PubMed  Google Scholar 

  60. Adams RB, Aloia TA, Loyer E, Pawlik TM, Taouli B, Vauthey JN, Americas Hepato-Pancreato-Biliary Association, Society of Surgical Oncology, Society for Surgery of the Alimentary Tract et al (2013) Selection for hepatic resection of colorectal liver metastases: expert consensus statement. HPB 15:91–103

    Article  PubMed  PubMed Central  Google Scholar 

  61. Hwang M, Jayakrishnan TT, Green DE, George B, Thomas JP, Groeschl RT, Erickson B, Pappas SG, Gamblin TC, Turaga KK et al (2014) Systematic review of outcomes of patients undergoing resection for colorectal liver metastases in the setting of extra-hepatic disease. Eur J Cancer 50:1747–1757

    Article  PubMed  Google Scholar 

  62. Hadden WJ, de Reuver PR, Brown K, Mittal A, Samra JS, Hugh TJ et al (2016) Resection of colorectal liver metastases and extra-hepatic disease: a systematic review and proportional meta-analysis of survival outcomes. HPB 18:209–220

    Article  PubMed  PubMed Central  Google Scholar 

  63. Leung U, Gönen M, Allen PJ, Kingham TP, DeMatteo R, Jarnagin WR, D'Angelica MI et al (2017) Colorectal cancer liver metastases and concurrent extrahepatic disease treated with resection. Ann Surg 265:158–165

    Article  PubMed  Google Scholar 

  64. Lykoudis PM, O’Reilly D, Nastos K, Fusai G (2014) Systematic review of surgical management of synchronous colorectal liver metastases. Br J Surg 101(6):605–612

    Article  CAS  PubMed  Google Scholar 

  65. Power DG, Kemeny NE (2010) Role of adjuvant therapy after resection of colorectal cancer liver metastases. J Clin Oncol 28(13):2300–2309

    Article  CAS  PubMed  Google Scholar 

  66. Langer B, Bleiberg H, Labianca R et al (2002) Fluorouracil (FU) plus I-Leucovorin (i-LV) versus observation after potentially curative resection of liver or lung metastases from colorectal cancer (CRC); results of the ENG (EORTC/NCIC CTG/GIVIO) randomized trial. Proc Am Soc Clin Oncol 21(S1):149a

    Google Scholar 

  67. Lopez-Ladron A, Salvador AJ, Bernabe R (2003) Observation versus postoperative chemotherapy after resection of liver metastases in patients with advanced colorectal cancer. Proc Am Soc Clin Oncol 22(373):abstr 1497

    Google Scholar 

  68. Portier G, Elias D, Bouche O, Rougier P, Bosset JF, Saric J et al (2006) Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial. J Clin Oncol 24(31):4976–4982

    Article  CAS  PubMed  Google Scholar 

  69. Ychou M, Hohenberger W, Thezenas S, Navarro M, Maurel J, Bokemeyer C, Shacham-Shmueli E, Rivera F, Kwok-Keung Choi C, Santoro A et al (2009) A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer. Ann Oncol 20(12):1964–1970

    Article  CAS  PubMed  Google Scholar 

  70. Rubbia-Brandt L, Giostra E, Brezault C, Roth AD, Andres A, Audard V, Sartoretti P, Dousset B, Majno PE, Soubrane O, Chaussade S, Mentha G, Terris B et al (2007) Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery. Ann Oncol 18:299–304

    Article  CAS  PubMed  Google Scholar 

  71. Nordlinger B, Sorbye H, Glimelius B, Poston G, Schlag P, Rougier P, Bechstein WO, Primrose JN, Walpole ET, Finch-Jones M, Jaeck D, Mirza D, Parks RW, Collette L, Praet M, Bethe U, van Cutsem E, Scheithauer W, Gruenberger T, EORTC Gastro-Intestinal Tract Cancer Group, Cancer Research UK, Arbeitsgruppe Lebermetastasen und-tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie (ALM-CAO), Australasian Gastro-Intestinal Trials Group (AGITG), Fédération Francophone de Cancérologie Digestive (FFCD) et al (2008) Perioperative chemo with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer; a RCT. Lancet 371:1007–1016

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P et al (2013) Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. Lancet Oncol 14(12):1208–1215

    Article  CAS  PubMed  Google Scholar 

  73. Fong Y (2013) Chemotherapy and resection for colorectal metastases. Lancet Oncol 14:1148–1149

    Article  CAS  PubMed  Google Scholar 

  74. Wicherts DA, de Haas RJ, Sebagh M et al (2011) Regenerative nodular hyperplasia of the liver related to chemotherapy: impact on outcome of liver surgery for colorectal metastases. Ann Surg Oncol 18(3):659–669

    Article  PubMed  Google Scholar 

  75. Kneuertz PJ, Maithel SK, Staley CA, Kooby DA (2011) Chemotherapy-associated liver injury: impact on surgical management of colorectal cancer liver metastases. Ann Surg Oncol 18:181–190

    Article  PubMed  Google Scholar 

  76. Vauthey JN, Pawlik TM, Ribero D, Wu TT, Zorzi D, Hoff PM, Xiong HQ, Eng C, Lauwers GY, Mino-Kenudson M, Risio M, Muratore A, Capussotti L, Curley SA, Abdalla EK et al (2006) Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 24:2065–2072

    Article  CAS  PubMed  Google Scholar 

  77. Pawlik TM, Olino K, Gleisner AL, Torbenson M, Schulick R, Choti MA et al (2007) Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome. J Gastrointest Surg 11(7):860–868

    Article  PubMed  Google Scholar 

  78. Parkin E, O’Reilly DA, Adam R et al (2014) Equivalent survival in patients with and without steatosis undergoing resection for colorectal liver metastases following pre-operative chemotherapy. Eur J Surg Oncol 40(11):1436–1444

    Article  CAS  PubMed  Google Scholar 

  79. Kishi Y, Zorzi D, Contreras CM, Maru DM, Kopetz S, Ribero D, Motta M, Ravarino N, Risio M, Curley SA, Abdalla EK, Capussotti L, Vauthey JN et al (2010) Extended preoperative chemotherapy does not improve pathologic response and increases postoperative liver insufficiency after hepatic resection for colorectal liver metastases. Ann Surg Oncol 17:2870–2876

    Article  PubMed  Google Scholar 

  80. Soubrane O, Brouquet A, Zalinski S, Terris B, Brézault C, Mallet V, Goldwasser F, Scatton O et al (2010) Predicting high grade lesions of sinusoidal obstruction syndrome related to oxaliplatin-based chemotherapy for colorectal liver metastases: correlation with post-hepatectomy outcome. Ann Surg 251:454–460

    Article  PubMed  Google Scholar 

  81. Vauthey JN, Mizuno T, Overman MJ, Soubrane O (2017) Can we navigate chemotherapy-induced hepatic injuries from pathology to bedside? J Hepatol 67(1):10–11

    Article  PubMed  Google Scholar 

  82. Goodman KA, Kavanagh BD (2017) Stereotactic body radiotherapy for liver metastases. Semin Radiat Oncol 27:240–246

    Article  PubMed  Google Scholar 

  83. Rule W, Timmerman R, Tong L, Abdulrahman R, Meyer J, Boike T, Schwarz RE, Weatherall P, Chinsoo Cho L et al (2011) Phase I dose-escalation study of stereotactic body radiotherapy in patients with hepatic metastases. Ann Surg Oncol 18(4):1081–1087

    Article  PubMed  Google Scholar 

  84. Kemeny N, Huang Y, Cohen AM, Shi W, Conti JA, Brennan MF, Bertino JR, Turnbull AD, Sullivan D, Stockman J, Blumgart LH, Fong Y et al (1999) Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 341(27):2039–2048

    Article  CAS  PubMed  Google Scholar 

  85. Kemeny NE, Gonen M (2005) Hepatic arterial infusion after liver resection. N Engl J Med 352(7):734–735

    Article  CAS  PubMed  Google Scholar 

  86. Zervoudakis A, Boucher T, Kemeny NE (2017) Treatment options in colorectal liver metastases: hepatic arterial infusion. Visc Med 33:47–53

    Article  PubMed  PubMed Central  Google Scholar 

  87. Lewis HL, Bloom M (2016) Hepatic artery infusional chemotherapy. Surg Clin N Am 96:341–355

    Article  PubMed  Google Scholar 

  88. Fiorentini G, Aliberti C, Tilli M, Mulazzani L, Graziano F, Giordani P, Mambrini A, Montagnani F, Alessandroni P, Catalano V, Coschiera P et al (2012) Intra-arterial infusion of irinotecan-loaded drug-eluting beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: final results of a phase III study. Anticancer Res 32(4):1387–1395

    CAS  PubMed  Google Scholar 

  89. Karagkounis G, Torbenson MS, Daniel HD et al (2013) Incidence and prognostic impact of KRAS and BRAF mutation in patients undergoing liver surgery for colorectal metastases. Cancer 119(23):4137–4144

    Article  CAS  PubMed  Google Scholar 

  90. Margonis GA, Sasaki K, Kim Y, Samaha M, Buettner S, Amini N, Antoniou E, Pawlik TM et al (2016) Tumor biology rather than surgical technique dictates prognosis in colorectal cancer liver metastases. J Gastrointest Surg 20(11):1821–1829

    Article  PubMed  Google Scholar 

  91. Hellman S, Weichselbaum RR (1995) Oligometastases. J Clin Oncol 13(1):8–10

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgical Oncology, Saroj Gupta Cancer Centre & Research Institute, Thakurpukur, Kolkata, India

    Bhattacharyya Samir & Gupta Arnab

Authors
  1. Bhattacharyya Samir
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gupta Arnab
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gupta Arnab.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Samir, B., Arnab, G. Colorectal Liver Metastasis: Current Concepts. Indian J Surg 83 (Suppl 3), 637–646 (2021). https://doi.org/10.1007/s12262-019-02051-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12262-019-02051-7

Keywords

Search

Navigation